Comments
Loading...

Poseida Therapeutics

PSTXNASDAQ
Logo brought to you by Benzinga Data
$3.46
-0.05-1.49%
Pre-Market: 5:48 PM EDT
15 minutes delayed

Poseida Therapeutics (NASDAQ:PSTX) Stock, Earnings Estimates, EPS, And Revenue

Poseida Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 7
EPS Estimate
$-0.410
Quarterly Revenue Estimate
$16.3M
Annual Revenue
(as of Jun 30)
$88.5M

Analyze the earnings history of Poseida Therapeutics using advanced sorting and filters.

Data brought to you by Benzinga APIs

Poseida Therapeutics (PSTX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal Quarter EndDate ReportedActual EPSEstimated EPSSurprise %
Jun 20242024-08-05$-0.32$-0.4121.9 %
Mar 20242024-05-14$-0.25$-0.4240.5 %
Dec 20232024-03-07$-0.27$-0.3930.8 %
Sep 20232023-11-09$-0.35$-0.29-20.7 %

Poseida Therapeutics (PSTX) Revenue

Quarterly Revenue Surprise Amount

Fiscal Quarter EndDate ReportedActual RevenueEstimated RevenueSurprise %
Jun 20242024-08-05$25.97M$15.43M68.3 %
Mar 20242024-05-14$28.14M$11.67M141.2 %
Dec 20232024-03-07$25.00M$6.65M275.9 %
Sep 20232023-11-09$9.35M$18.87M-50.4 %

FAQ

Q

When is Poseida Therapeutics (NASDAQ:PSTX) reporting earnings?

A

Poseida Therapeutics (PSTX) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 5, 2024 for Q2.

Q

What were the latest earnings per share (EPS) for Poseida Therapeutics (NASDAQ:PSTX)?

A

The Actual EPS was $-0.32, which beat the estimate of $-0.41.

Q

What were Poseida Therapeutics’s (NASDAQ:PSTX) revenues?

A

The Actual Revenue was $26M, which beat the estimate of $15.4M.

Browse earnings estimates, EPS, and revenue on all stocks.

People Also Watch